CNS Drugs

Cytomegalovirus and Schizophrenia
pp. 879-885(7)
Authors: Torrey, E. Fuller; Leweke, Markus F.; Schwarz, Markus J.; Mueller, Norbert; Bachmann, Silke; Schroeder, Johannes; Dickerson, Faith; Yolken, Robert H.

Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date
pp. 887-896(10)
Author: Valdez, Glenn R.

Psychiatric Manifestations of Graves' Hyperthyroidism: Pathophysiology and Treatment Options
pp. 897-909(13)
Authors: Bunevicius, Robertas; Prange, Arthur J.

Epilepsy with Myoclonic Absences
pp. 911-916(6)
Authors: Genton, Pierre; Bureau, Michelle

Neuraxial Drug Administration: A Review of Treatment Options for Anaesthesia and Analgesia
pp. 917-933(17)
Authors: Schug, Stephan A.; Saunders, David; Kurowski, Irina; Paech, Michael J.

A Naturalistic Study of Galantamine for Alzheimer's Disease
pp. 935-943(9)
Authors: Brodaty, Henry; Woodward, Michael; Boundy, Karyn; Barnes, Nicola; Allen, Gabrielle

Varenicline: A Review of its Use as an Aid to Smoking Cessation Therapy
pp. 945-960(16)
Authors: Keating, Gillian M.; Siddiqui, M. Asif A.

Spotlight on Eletriptan in Migraine
pp. 961-964(4)
Authors: McCormack, Paul L.; Keating, Gillian M.